| NTP_ICE_endocrine |
AC50 |
0.669617515126504 |
uM |
- |
- |
- |
ERPathway2016; ER Pathway Model, Antagonist |
sheet=Integrated_approaches; excel_row=5646; RecordID=ERPathway2016_161; DatasetName=ERPathway2016; DTXSID=DTXSID7020182; Assay=ER Pathway Model, Antagonist; Endpoint=AC50; Response=0.669617515126504; Response_Unit=uM; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
AC50 |
16.8348356403529 |
uM |
- |
- |
- |
ARPathway2016; AR Pathway Model, Agonist |
sheet=Integrated_approaches; excel_row=5640; RecordID=ARPathway2016_286; DatasetName=ARPathway2016; DTXSID=DTXSID7020182; Assay=AR Pathway Model, Agonist; Endpoint=AC50; Response=16.8348356403529; Response_Unit=uM; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
AC50/EC50/IC50 |
0.1585 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13115; Record_ID=endocrine_invitro_2690; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=AC50/EC50/IC50; Reported_Response=0.15848931899999999; Reported_Response_Unit=nM; Response=0.1585; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
AC50/EC50/IC50 |
80 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13318; Record_ID=endocrine_invitro_1469; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=AC50/EC50/IC50; Reported_Response=80; Reported_Response_Unit=nM; Response=80; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Lee et al. 2003; 12805653; 10.1093/toxsci/kfg150; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
AC50/EC50/IC50 |
158.489 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13257; Record_ID=endocrine_invitro_2761; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=AC50/EC50/IC50; Reported_Response=158.489; Reported_Response_Unit=nM; Response=158.489; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
AC50/EC50/IC50 |
318 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13317; Record_ID=endocrine_invitro_1471; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=AC50/EC50/IC50; Reported_Response=318; Reported_Response_Unit=nM; Response=318; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Lee et al. 2003; 12805653; 10.1093/toxsci/kfg150; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
AC50/EC50/IC50 |
746 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13253; Record_ID=endocrine_invitro_1732; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=AC50/EC50/IC50; Reported_Response=746; Reported_Response_Unit=nM; Response=746; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Xu et al. 2005; 16169144; 10.1016/j.tox.2005.08.006; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
AC50/EC50/IC50 |
920 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13509; Record_ID=endocrine_invitro_2651; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=AC50/EC50/IC50; Reported_Response=920; Reported_Response_Unit=nM; Response=920; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Molina-Molina et al. 2013; 23714657; 10.1016/j.taap.2013.05.015; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
AC50/EC50/IC50 |
1800 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13277; Record_ID=endocrine_invitro_1461; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=AC50/EC50/IC50; Reported_Response=1.8; Reported_Response_Unit=uM; Conversion_Factor=1000; Conversion_Factor_Value=1000; Converted_Response=1800; Converted_Response_Unit=nM; Response=1800; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Lee et al. 2003; 12805653; 10.1093/toxsci/kfg150; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
AC50/EC50/IC50 |
2340 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13240; Record_ID=endocrine_invitro_2599; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=AC50/EC50/IC50; Reported_Response=2340; Reported_Response_Unit=nM; Response=2340; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Teng et al. 2013; 23562765; 10.1016/j.cbi.2013.03.013; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
AC50/EC50/IC50 |
2500 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13238; Record_ID=endocrine_invitro_2829; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=AC50/EC50/IC50; Reported_Response=2500; Reported_Response_Unit=nM; Response=2500; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
AC50/EC50/IC50 |
2800 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13248; Record_ID=endocrine_invitro_1494; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=AC50/EC50/IC50; Reported_Response=2800; Reported_Response_Unit=nM; Response=2800; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Willemsen et al. 2004; 14513195; 10.1007/s00216-003-2217-2; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
AC50/EC50/IC50 |
3200 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13242; Record_ID=endocrine_invitro_2002; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=AC50/EC50/IC50; Reported_Response=3200; Reported_Response_Unit=nM; Response=3200; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Krüger et al. 2008; 18294747; 10.1016/j.tox.2007.12.028; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
AC50/EC50/IC50 |
4200 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13281; Record_ID=endocrine_invitro_2253; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=AC50/EC50/IC50; Reported_Response=4200; Reported_Response_Unit=nM; Response=4200; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
AC50/EC50/IC50 |
4300 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13519; Record_ID=endocrine_invitro_1669; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=AC50/EC50/IC50; Reported_Response=4300; Reported_Response_Unit=nM; Response=4300; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Kitamura et al. 2005; 15635150; 10.1093/toxsci/kfi074; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
AC50/EC50/IC50 |
5000 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13517; Record_ID=endocrine_invitro_1685; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=AC50/EC50/IC50; Reported_Response=5000; Reported_Response_Unit=nM; Response=5000; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Michelini et al. 2005; 15797324; 10.1016/j.bios.2004.10.018; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
AC50/EC50/IC50 |
5250 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13511; Record_ID=endocrine_invitro_1885; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=AC50/EC50/IC50; Reported_Response=5250; Reported_Response_Unit=nM; Response=5250; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Tamura et al. 2006; 16876421; 10.1016/j.bmc.2006.06.064; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
AC50/EC50/IC50 |
5700 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13493; Record_ID=endocrine_invitro_1889; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=AC50/EC50/IC50; Reported_Response=5700; Reported_Response_Unit=nM; Response=5700; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Tamura et al. 2006; 16876421; 10.1016/j.bmc.2006.06.064; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
AC50/EC50/IC50 |
7000 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13515; Record_ID=endocrine_invitro_3097; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=AC50/EC50/IC50; Reported_Response=7000; Reported_Response_Unit=nM; Response=7000; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Paris et al. 2002; 12161000; 10.1016/s0303-7207(02)00094-1; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
AC50/EC50/IC50 |
7900 |
nM |
- |
- |
- |
In Vitro; AR Binding |
sheet=Data_invitro; excel_row=165; Record_ID=endocrine_invitro_159; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Binding; Endpoint=AC50/EC50/IC50; Reported_Response=7900; Reported_Response_Unit=nM; Response=7900; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
AC50/EC50/IC50 |
11800 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13244; Record_ID=endocrine_invitro_2535; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=AC50/EC50/IC50; Reported_Response=11800; Reported_Response_Unit=nM; Response=11800; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Rostkowski et al. 2011; 22047186; 10.1021/es202966c; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
AC50/EC50/IC50 |
19600 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13520; Record_ID=endocrine_invitro_1571; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=AC50/EC50/IC50; Reported_Response=19600; Reported_Response_Unit=nM; Response=19600; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
AC50/EC50/IC50 |
39000 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13513; Record_ID=endocrine_invitro_2936; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=AC50/EC50/IC50; Reported_Response=39000; Reported_Response_Unit=nM; Response=39000; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Roelofs et al. 2015; 25576683; 10.1016/j.tox.2015.01.003; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
AC50/EC50/IC50 |
55380 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Agonist |
sheet=Data_invitro; excel_row=8329; Record_ID=endocrine_invitro_2650; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Agonist; Endpoint=AC50/EC50/IC50; Reported_Response=55380; Reported_Response_Unit=nM; Response=55380; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Molina-Molina et al. 2013; 23714657; 10.1016/j.taap.2013.05.015; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
AC50/EC50/IC50 |
62700 |
nM |
- |
- |
- |
In Vitro; AR Binding |
sheet=Data_invitro; excel_row=517; Record_ID=endocrine_invitro_511; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Binding; Endpoint=AC50/EC50/IC50; Reported_Response=62700; Reported_Response_Unit=nM; Response=62700; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Oehlmann et al. 2006; 16818258; 10.1289/ehp.8065; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
AC50/EC50/IC50 |
75000 |
nM |
- |
- |
- |
In Vitro; AR Binding |
sheet=Data_invitro; excel_row=169; Record_ID=endocrine_invitro_163; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Binding; Endpoint=AC50/EC50/IC50; Reported_Response=75000; Reported_Response_Unit=nM; Response=75000; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Fang et al. 2003; 14565775; 10.1021/tx030011g; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
AC50/EC50/IC50 |
110000 |
nM |
- |
- |
- |
In Vitro; AR Binding |
sheet=Data_invitro; excel_row=167; Record_ID=endocrine_invitro_161; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Binding; Endpoint=AC50/EC50/IC50; Reported_Response=110000; Reported_Response_Unit=nM; Response=110000; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Kim et al. 2010; 20371976; 10.2131/jts.35.239; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
AC50/EC50/IC50 |
1000001453 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13104; Record_ID=endocrine_invitro_2593; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=AC50/EC50/IC50; Reported_Response=1000001453; Reported_Response_Unit=nM; Response=1000001453; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
ACC |
0.228354371372336 |
uM |
- |
- |
- |
ERPathway2016; ER Pathway Model, Antagonist |
sheet=Integrated_approaches; excel_row=5647; RecordID=ERPathway2016_161; DatasetName=ERPathway2016; DTXSID=DTXSID7020182; Assay=ER Pathway Model, Antagonist; Endpoint=ACC; Response=0.228354371372336; Response_Unit=uM; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
ACC |
17.0951719331564 |
uM |
- |
- |
- |
ARPathway2016; AR Pathway Model, Agonist |
sheet=Integrated_approaches; excel_row=5641; RecordID=ARPathway2016_286; DatasetName=ARPathway2016; DTXSID=DTXSID7020182; Assay=AR Pathway Model, Agonist; Endpoint=ACC; Response=17.0951719331564; Response_Unit=uM; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
EC50 |
533 |
nM |
- |
- |
- |
In Vitro; ER Transactivation-Agonist (VM7Luc Assay) |
sheet=Data_invitro; excel_row=16595; Record_ID=endocrine_invitro_4468; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=ER Transactivation-Agonist (VM7Luc Assay); Endpoint=EC50; Reported_Response=5.3300000000000002E-7; Reported_Response_Unit=M; Conversion_Factor=1000000000; Conversion_Factor_Value=1000000000; Converted_Response=533; Converted_Response_Unit=nM; Response=533; Response_Unit=nM; Reference=|OECD TG 455; https://www.oecd.org/env/test-no-455-performance-based-test-guideline-for-stably-transfected-transactivation-in-vitro-assays-to-detect-estrogen-receptor-9789264265295-en.htm; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
IC01 |
408 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13015; Record_ID=endocrine_invitro_2679; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=IC01; Reported_Response=408; Reported_Response_Unit=IC01 (nM); Response=408; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
IC20 |
<10000 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13026; Record_ID=endocrine_invitro_2900; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=IC20; Response_Modifier=<; Reported_Response_Modifier=<; Reported_Response=10000; Reported_Response_Unit=IC20 (nM); Response=10000; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
IC25 |
<1000 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13067; Record_ID=endocrine_invitro_2029; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=IC25; Response_Modifier=<; Reported_Response_Modifier=<; Reported_Response=1000; Reported_Response_Unit=IC25 (nM); Response=1000; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Bonefeld-Jørgensen et al. 2007; 18174953; 10.1289/ehp.9368; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
IC50 |
1500 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13279; Record_ID=endocrine_invitro_2958; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=IC50; Reported_Response=1.5E-6; Reported_Response_Unit=IC50 (M); Conversion_Factor=1000000000; Conversion_Factor_Value=1000000000; Converted_Response=1500; Converted_Response_Unit=nM; Response=1500; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Lee et al. 2003; 12805653; 10.1093/toxsci/kfg150; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
IC50 |
3350 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13390; Record_ID=endocrine_invitro_2735; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=IC50; Reported_Response=3.35; Reported_Response_Unit=IC50 (uM); Conversion_Factor=1000; Conversion_Factor_Value=1000; Converted_Response=3350; Converted_Response_Unit=nM; Response=3350; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Fic et al. 2014; 25048928; 10.1016/j.chemosphere.2014.04.080; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
IC50 |
81000 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13392; Record_ID=endocrine_invitro_2964; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=IC50; Reported_Response=8.1000000000000004E-5; Reported_Response_Unit=IC50 (M); Conversion_Factor=1000000000; Conversion_Factor_Value=1000000000; Converted_Response=81000; Converted_Response_Unit=nM; Response=81000; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Ki |
18000 |
nM |
- |
- |
- |
In Vitro; AR Binding |
sheet=Data_invitro; excel_row=1865; Record_ID=endocrine_invitro_1098; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Binding; Endpoint=Ki; Reported_Response=18000; Reported_Response_Unit=nM; Response=18000; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Lee et al. 2003; 12805653; 10.1093/toxsci/kfg150; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
LEL |
0.1 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=14955; Record_ID=endocrine_invitro_1573; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=LEL; Reported_Response=0.1; Reported_Response_Unit=nM; Response=0.1; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Stroheker et al. 2004; 15110097; 10.1016/j.fct.2004.01.012; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
LEL |
1 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Agonist |
sheet=Data_invitro; excel_row=10778; Record_ID=endocrine_invitro_2917; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Agonist; Endpoint=LEL; Reported_Response=1; Reported_Response_Unit=nM; Response=1; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
LEL |
10 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=15118; Record_ID=endocrine_invitro_2347; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=LEL; Reported_Response=10; Reported_Response_Unit=nM; Response=10; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Christen et al. 2010; 20943248; 10.1016/j.chemosphere.2010.09.031; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
LEL |
100 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=14953; Record_ID=endocrine_invitro_1732; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=LEL; Reported_Response=100; Reported_Response_Unit=nM; Response=100; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Xu et al. 2005; 16169144; 10.1016/j.tox.2005.08.006; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
LEL |
199.5 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=14957; Record_ID=endocrine_invitro_2651; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=LEL; Reported_Response=199.52600000000001; Reported_Response_Unit=nM; Response=199.5; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Molina-Molina et al. 2013; 23714657; 10.1016/j.taap.2013.05.015; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
LEL |
600 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=14961; Record_ID=endocrine_invitro_1988; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=LEL; Reported_Response=600; Reported_Response_Unit=nM; Response=600; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Bonefeld-Jørgensen et al. 2007; 18174953; 10.1289/ehp.9368; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
LEL |
1584.89 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=14949; Record_ID=endocrine_invitro_1273; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=LEL; Reported_Response=1584.89; Reported_Response_Unit=nM; Response=1584.89; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
LEL |
2000 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=14963; Record_ID=endocrine_invitro_2250; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=LEL; Reported_Response=2000; Reported_Response_Unit=nM; Response=2000; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Ermler et al. 2010; 20488240; 10.1016/j.tiv.2010.05.007; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
LEL |
3000 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=14951; Record_ID=endocrine_invitro_3097; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=LEL; Reported_Response=3000; Reported_Response_Unit=nM; Response=3000; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Paris et al. 2002; 12161000; 10.1016/s0303-7207(02)00094-1; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
LEL |
4380 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=14970; Record_ID=endocrine_invitro_2583; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=LEL; Reported_Response=1000000; Reported_Response_Unit=ng/L; Conversion_Factor=Molecular Weight; Conversion_Factor_Value=228.291; Conversion_Factor_Source=EPA Dashboard; Converted_Response=4380.3741715617352; Converted_Response_Unit=nM; Response=4380; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
LEL |
10000 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Agonist |
sheet=Data_invitro; excel_row=10556; Record_ID=endocrine_invitro_2650; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Agonist; Endpoint=LEL; Reported_Response=10000; Reported_Response_Unit=nM; Response=10000; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Molina-Molina et al. 2013; 23714657; 10.1016/j.taap.2013.05.015; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
LOEL |
2 |
mg/kg bw/day |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 19; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=1014; Record_ID=endocrine_invivo_361; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=LOEL; Response=2; Response_Unit=mg/kg/day; Species=Rat; Sex=Female; Route=Subcutaneous; Maximum_Dose=200; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Estradiol; Reference=Takeyoshi 2006; Not available; https://www.oecd.org/env/ehs/testing/37504278.pdf|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
LOEL |
10 |
mg/kg bw/day |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 18; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=1016; Record_ID=endocrine_invivo_456; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=LOEL; Response=10; Response_Unit=mg/kg/day; Species=Rat; Reported_Strain=Hsd:SD; Strain=Sprague-Dawley; Sex=Female; Route=Subcutaneous; Maximum_Dose=1000; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol B; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
LOEL |
20 |
mg/kg bw/day |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 20 to 22; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=1011; Record_ID=endocrine_invivo_358; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=LOEL; Response=20; Response_Unit=mg/kg/day; Species=Rat; Reported_Strain=Crj:CD(SD); Strain=Sprague-Dawley; Sex=Female; Route=Subcutaneous; Maximum_Dose=200; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Estradiol; Reference=Yamasaki et al. 2002; 11750080; 10.1016/s0300-483x(01)00505-4|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
LOEL |
30 |
mg/kg bw/day |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 19 to 20; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=4 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=1022; Record_ID=endocrine_invivo_375; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=LOEL; Response=30; Response_Unit=mg/kg/day; Species=Rat; Reported_Strain=Ap; Strain=Alderley Park; Sex=Female; Route=Subcutaneous; Maximum_Dose=300; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Experiment 3; Reference=Tinwell and Ashby 2004; 15064164; 10.1289/ehp.6831|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
LOEL |
50 |
mg/kg bw/day |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 84; Age_Ovariectomized_or_Castrated=8 Weeks; Time_Elapsed_Between_Surgery_and_Treatment=4 weeks; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=988; Record_ID=endocrine_invivo_455; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=LOEL; Response=50; Response_Unit=mg/kg/day; Species=Rat; Reported_Strain=Jcl:Sprague-Dawley; Strain=Sprague-Dawley; Sex=Female (ovariectomized); Route=Subcutaneous; Maximum_Dose=100; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Estradiol; Reference=Takemura et al. 2005; 15596252; 10.1016/j.tox.2004.09.015|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
LOEL |
75 |
mg/kg bw/day |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 19 to 20; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=2 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=1018; Record_ID=endocrine_invivo_369; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=LOEL; Response=75; Response_Unit=mg/kg/day; Species=Rat; Reported_Strain=Ap; Strain=Alderley Park; Sex=Female; Route=Subcutaneous; Maximum_Dose=75; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Experiment 6; Reference=Tinwell and Ashby 2004; 15064164; 10.1289/ehp.6831|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
LOEL |
100 |
mg/kg bw/day |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 56 to 84; Age_Ovariectomized_or_Castrated=6 weeks; Time_Elapsed_Between_Surgery_and_Treatment=14 to 28 days; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=999; Record_ID=endocrine_invivo_349; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=LOEL; Response=100; Response_Unit=mg/kg/day; Species=Rat; Reported_Strain=Crl:CD(SD)IGS BR; Strain=Sprague-Dawley; Sex=Female (ovariectomized); Route=Subcutaneous; Maximum_Dose=600; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol C; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
LOEL |
200 |
mg/kg bw/day |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 21; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=4 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=1013; Record_ID=endocrine_invivo_360; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=LOEL; Response=200; Response_Unit=mg/kg/day; Species=Rat; Reported_Strain=SD; Strain=Sprague-Dawley; Sex=Female; Route=Subcutaneous; Maximum_Dose=200; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Estradiol; Reference=Ohno et al. 2003; 12453737; 10.1016/s0278-6915(02)00211-9|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
LOEL |
300 |
mg/kg bw/day |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 18; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=1004; Record_ID=endocrine_invivo_342; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=LOEL; Response=300; Response_Unit=mg/kg/day; Species=Rat; Reported_Strain=Wistar (Hsd/Cpb:WU); Strain=Wistar; Sex=Female; Route=Subcutaneous; Maximum_Dose=1000; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol B; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
LOEL |
375 |
mg/kg bw/day |
Rat |
Oral |
Treatment_Duration=3 days; Age_at_First_Dose=PND 18; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=1009; Record_ID=endocrine_invivo_356; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=LOEL; Response=375; Response_Unit=mg/kg/day; Species=Rat; Reported_Strain=Crl:CD(SD)IGS BR; Strain=Sprague-Dawley; Sex=Female; Route=Oral; Maximum_Dose=600; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol A; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
LOEL |
400 |
mg/kg bw/day |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 21; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=2 to 3 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=1015; Record_ID=endocrine_invivo_364; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=LOEL; Response=400; Response_Unit=mg/kg/day; Species=Rat; Reported_Strain=Alpk:AP; Strain=Alderley Park; Sex=Female; Route=Subcutaneous; Maximum_Dose=600; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Diethylstilbestrol; Reference=Ashby and Tonwell 1998; 9799186; 10.1289/ehp.98106719|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
LOEL |
600 |
mg/kg bw/day |
Rat |
Oral |
Treatment_Duration=3 days; Age_at_First_Dose=PND 18; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=1010; Record_ID=endocrine_invivo_357; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=LOEL; Response=600; Response_Unit=mg/kg/day; Species=Rat; Reported_Strain=Crj:CD(SD)IGS; Strain=Sprague-Dawley; Sex=Female; Route=Oral; Maximum_Dose=1000; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol A; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
LOEL |
800 |
mg/kg bw/day |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 21 to 22; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=7 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=1005; Record_ID=endocrine_invivo_354; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=LOEL; Response=800; Response_Unit=mg/kg/day; Species=Rat; Reported_Strain=Alpk:APfSD; Strain=Alderley Park; Sex=Female; Route=Subcutaneous; Maximum_Dose=800; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Estradiol; Reference=Matthews et al. 2001; 11258963; 10.1021/tx0001833|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
LOEL |
1000 |
mg/kg bw/day |
Rat |
Oral |
Treatment_Duration=3 days; Age_at_First_Dose=PND 18; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=1019; Record_ID=endocrine_invivo_368; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=LOEL; Response=1000; Response_Unit=mg/kg/day; Species=Rat; Reported_Strain=SPF-bred Wistar, HSD/Cpb:WU; Strain=Wistar; Sex=Female; Route=Oral; Maximum_Dose=1000; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol A; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Model Score |
0 |
unitless |
- |
- |
- |
ARPathway2016; AR Pathway Model, Agonist |
sheet=Integrated_approaches; excel_row=5643; RecordID=ARPathway2016_286; DatasetName=ARPathway2016; DTXSID=DTXSID7020182; Assay=AR Pathway Model, Agonist; Endpoint=Model Score; Response=0; Response_Unit=Unitless; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Model Score |
0.345 |
unitless |
- |
- |
- |
ARPathway2016; AR Pathway Model, Antagonist |
sheet=Integrated_approaches; excel_row=5642; RecordID=ARPathway2016_286; DatasetName=ARPathway2016; DTXSID=DTXSID7020182; Assay=AR Pathway Model, Antagonist; Endpoint=Model Score; Response=0.345; Response_Unit=Unitless; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Model Score |
0.45 |
unitless |
- |
- |
- |
ERPathway2016; ER Pathway Model, Agonist |
sheet=Integrated_approaches; excel_row=5648; RecordID=ERPathway2016_161; DatasetName=ERPathway2016; DTXSID=DTXSID7020182; Assay=ER Pathway Model, Agonist; Endpoint=Model Score; Response=0.45; Response_Unit=Unitless; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
NOEL |
600 |
mg/kg bw/day |
Rat |
Oral |
Treatment_Duration=10 days; Age_at_First_Dose=PND 56; Age_Ovariectomized_or_Castrated=PND 42; Time_Elapsed_Between_Surgery_and_Treatment=14 days; Time_Elapsed_Between_Last_Dose_and_Necropsy=18 to 36 hours; Number_of_Doses_Tested=6 |
In Vivo; Hershberger-Agonist |
sheet=Data_invivo; excel_row=2189; Record_ID=endocrine_invivo_941; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Hershberger-Agonist; Endpoint=NOEL; Response=600; Response_Unit=mg/kg/day; Species=Rat; Reported_Strain=Sprague-Dawley; Strain=Sprague-Dawley; Sex=Male (castrated); Route=Oral; Reference_Hormone=Testosterone propionate; Reference_Hormone_Dose=0.2; Reference_Hormone_Dose_Units=mg/kg/day; Reference_Hormone_Route=Subcutaneous; Additional_Information=Browne et al. 2018 unique record identifier 264; Reference=Yamasaki et al. 2003; 12504345; 10.1016/s0300-483x(02)00445-6|Browne et al. 2018; 30205136; 10.1016/j.reprotox.2018.08.016; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
PC50 |
294 |
nM |
- |
- |
- |
In Vitro; ER Transactivation-Agonist (STTA Assay) |
sheet=Data_invitro; excel_row=16542; Record_ID=endocrine_invitro_4468; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=ER Transactivation-Agonist (STTA Assay); Endpoint=PC50; Reported_Response=2.9400000000000001E-7; Reported_Response_Unit=M; Conversion_Factor=1000000000; Conversion_Factor_Value=1000000000; Converted_Response=294; Converted_Response_Unit=nM; Response=294; Response_Unit=nM; Reference=|OECD TG 455; https://www.oecd.org/env/test-no-455-performance-based-test-guideline-for-stably-transfected-transactivation-in-vitro-assays-to-detect-estrogen-receptor-9789264265295-en.htm; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
RBA |
0.004074 |
unitless |
- |
- |
- |
In Vitro; AR Binding |
sheet=Data_invitro; excel_row=1967; Record_ID=endocrine_invitro_163; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Binding; Endpoint=RBA; Reported_Response=-2.39; Reported_Response_Unit=Unitless; Conversion_Factor=Anti-log; Converted_Response=4.0738027780411225E-3; Converted_Response_Unit=Unitless; Response=0.004074; Response_Unit=Unitless; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Fang et al. 2003; 14565775; 10.1021/tx030011g; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
RBA |
0.0041 |
unitless |
- |
- |
- |
In Vitro; AR Binding |
sheet=Data_invitro; excel_row=2443; Record_ID=endocrine_invitro_163; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Binding; Endpoint=RBA; Reported_Response=4.1000000000000003E-3; Reported_Response_Unit=Unitless; Response=0.0041; Response_Unit=Unitless; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Fang et al. 2003; 14565775; 10.1021/tx030011g; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
RBA |
0.016 |
unitless |
- |
- |
- |
In Vitro; AR Binding |
sheet=Data_invitro; excel_row=2445; Record_ID=endocrine_invitro_161; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Binding; Endpoint=RBA; Reported_Response=1.6E-2; Reported_Response_Unit=Unitless; Response=1.6E-2; Response_Unit=Unitless; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Kim et al. 2010; 20371976; 10.2131/jts.35.239; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
RBA |
0.0301 |
unitless |
- |
- |
- |
In Vitro; AR Binding |
sheet=Data_invitro; excel_row=2442; Record_ID=endocrine_invitro_1102; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Binding; Endpoint=RBA; Reported_Response=3.0099999999999998E-2; Reported_Response_Unit=Unitless; Response=0.0301; Response_Unit=Unitless; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Liu et al. 2009; 19862954; 10.1016/s1001-0742(08)62356-6; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
RBA |
0.215 |
unitless |
- |
- |
- |
In Vitro; AR Binding |
sheet=Data_invitro; excel_row=2444; Record_ID=endocrine_invitro_164; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Binding; Endpoint=RBA; Reported_Response=0.215; Reported_Response_Unit=Unitless; Response=0.215; Response_Unit=Unitless; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
RIC20 |
1200 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13348; Record_ID=endocrine_invitro_3069; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=RIC20; Reported_Response=1200; Reported_Response_Unit=RIC20 (nM); Response=1200; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Relative potency |
45 |
% |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=15206; Record_ID=endocrine_invitro_2741; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=AR Transactivation-Antagonist; Endpoint=Relative potency; Reported_Response=45; Reported_Response_Unit=%; Response=45; Response_Unit=%; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Ermler et al. 2010; 20488240; 10.1016/j.tiv.2010.05.007; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Uterine weight increase vs control |
120 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 19; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=709; Record_ID=endocrine_invivo_361; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=120; Response_Unit=%; Species=Rat; Sex=Female; Route=Subcutaneous; Maximum_Dose=200; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Estradiol; Reference=Takeyoshi 2006; Not available; https://www.oecd.org/env/ehs/testing/37504278.pdf|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Uterine weight increase vs control |
124.1 |
% |
Rat |
Oral |
Treatment_Duration=3 days; Age_at_First_Dose=PND 21 to 22; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=8 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=711; Record_ID=endocrine_invivo_345; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=124.1; Response_Unit=%; Species=Rat; Reported_Strain=Alpk:APfSD; Strain=Alderley Park; Sex=Female; Route=Oral; Maximum_Dose=800.0; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Estradiol; Reference=Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Uterine weight increase vs control |
126 |
% |
Rat |
Oral |
Treatment_Duration=3 days; Age_at_First_Dose=PND 18; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=706; Record_ID=endocrine_invivo_341; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=126; Response_Unit=%; Species=Rat; Reported_Strain=SPF/VAF Crj:CD(SD)IGS; Strain=Sprague-Dawley; Sex=Female; Route=Oral; Maximum_Dose=1000; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol A; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Uterine weight increase vs control |
128 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 18; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=708; Record_ID=endocrine_invivo_344; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=128; Response_Unit=%; Species=Rat; Reported_Strain=SD; Strain=Sprague-Dawley; Sex=Female; Route=Subcutaneous; Maximum_Dose=1000; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol B; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Uterine weight increase vs control |
130 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 19 to 20; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=2 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=720; Record_ID=endocrine_invivo_382; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=130; Response_Unit=%; Species=Rat; Reported_Strain=Ap; Strain=Alderley Park; Sex=Female; Route=Subcutaneous; Maximum_Dose=75; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Experiment 4; Reference=Tinwell and Ashby 2004; 15064164; 10.1289/ehp.6831|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Uterine weight increase vs control |
131 |
% |
Rat |
Oral |
Treatment_Duration=3 days; Age_at_First_Dose=PND 18; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=690; Record_ID=endocrine_invivo_357; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=131; Response_Unit=%; Species=Rat; Reported_Strain=Crj:CD(SD)IGS; Strain=Sprague-Dawley; Sex=Female; Route=Oral; Maximum_Dose=1000; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol A; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Uterine weight increase vs control |
131.4 |
% |
Rat |
Oral |
Treatment_Duration=3 days; Age_at_First_Dose=PND 21; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=2 to 3 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=721; Record_ID=endocrine_invivo_348; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=131.4; Response_Unit=%; Species=Rat; Reported_Strain=Alpk:AP; Strain=Alderley Park; Sex=Female; Route=Oral; Maximum_Dose=600.0; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Diethylstilbestrol; Reference=Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Uterine weight increase vs control |
136 |
% |
Rat |
Oral |
Treatment_Duration=3 days; Age_at_First_Dose=PND 18; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=703; Record_ID=endocrine_invivo_356; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=136; Response_Unit=%; Species=Rat; Reported_Strain=Crl:CD(SD)IGS BR; Strain=Sprague-Dawley; Sex=Female; Route=Oral; Maximum_Dose=600; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol A; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Uterine weight increase vs control |
137 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 18; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=687; Record_ID=endocrine_invivo_342; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=137; Response_Unit=%; Species=Rat; Reported_Strain=Wistar (Hsd/Cpb:WU); Strain=Wistar; Sex=Female; Route=Subcutaneous; Maximum_Dose=1000; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol B; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Uterine weight increase vs control |
140 |
% |
Rat |
Oral |
Treatment_Duration=3 days; Age_at_First_Dose=PND 19 to 20; Time_Elapsed_Between_Last_Dose_and_Necropsy=4 or 24 hours; Number_of_Doses_Tested=8 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=714; Record_ID=endocrine_invivo_346; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=140; Response_Unit=%; Species=Rat; Reported_Strain=Alpk:APfSD (Wistar derived); Strain=Alderley Park; Sex=Female; Route=Oral; Maximum_Dose=800; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Estradiol; Reference=Ashby and Odum 2004; 15456929; 10.1093/toxsci/kfh283|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Uterine weight increase vs control |
141 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 20 to 22; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=705; Record_ID=endocrine_invivo_358; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=141; Response_Unit=%; Species=Rat; Reported_Strain=Crj:CD(SD); Strain=Sprague-Dawley; Sex=Female; Route=Subcutaneous; Maximum_Dose=200; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Estradiol; Reference=Yamasaki et al. 2002; 11750080; 10.1016/s0300-483x(01)00505-4|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Uterine weight increase vs control |
143 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 18; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=702; Record_ID=endocrine_invivo_377; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=143; Response_Unit=%; Species=Rat; Reported_Strain=Crl:CD(SD)BR; Strain=Sprague-Dawley; Sex=Female; Route=Subcutaneous; Maximum_Dose=1000; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol B; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Uterine weight increase vs control |
147 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 18; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=701; Record_ID=endocrine_invivo_355; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=147; Response_Unit=%; Species=Rat; Reported_Strain=Alpk:ApfSD; Strain=Alderley Park; Sex=Female; Route=Subcutaneous; Maximum_Dose=1000; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol B; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Uterine weight increase vs control |
149.5 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 21; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=2 to 3 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=691; Record_ID=endocrine_invivo_364; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=149.5; Response_Unit=%; Species=Rat; Reported_Strain=Alpk:AP; Strain=Alderley Park; Sex=Female; Route=Subcutaneous; Maximum_Dose=600.0; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Diethylstilbestrol; Reference=Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Uterine weight increase vs control |
150 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 19 to 20; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=2 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=704; Record_ID=endocrine_invivo_378; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=150; Response_Unit=%; Species=Rat; Reported_Strain=Ap; Strain=Alderley Park; Sex=Female; Route=Subcutaneous; Maximum_Dose=75; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Experiment 5; Reference=Tinwell and Ashby 2004; 15064164; 10.1289/ehp.6831|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Uterine weight increase vs control |
157 |
% |
Rat |
Oral |
Treatment_Duration=3 days; Age_at_First_Dose=PND 18; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=693; Record_ID=endocrine_invivo_368; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=157; Response_Unit=%; Species=Rat; Reported_Strain=SPF-bred Wistar, HSD/Cpb:WU; Strain=Wistar; Sex=Female; Route=Oral; Maximum_Dose=1000; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol A; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Uterine weight increase vs control |
160 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 56 to 84; Age_Ovariectomized_or_Castrated=6 weeks; Time_Elapsed_Between_Surgery_and_Treatment=14 to 28 days; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=695; Record_ID=endocrine_invivo_370; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=160; Response_Unit=%; Species=Rat; Reported_Strain=Alpk:ApfSD; Strain=Alderley Park; Sex=Female (ovariectomized); Route=Subcutaneous; Maximum_Dose=800; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol C; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Uterine weight increase vs control |
167 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 56 to 84; Age_Ovariectomized_or_Castrated=6 weeks; Time_Elapsed_Between_Surgery_and_Treatment=14 to 28 days; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=727; Record_ID=endocrine_invivo_350; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=167; Response_Unit=%; Species=Rat; Reported_Strain=Crj:CD(SD)IGS; Strain=Sprague-Dawley; Sex=Female (ovariectomized); Route=Subcutaneous; Maximum_Dose=800; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol C; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Uterine weight increase vs control |
172 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 18; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=688; Record_ID=endocrine_invivo_353; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=172; Response_Unit=%; Species=Rat; Reported_Strain=SPF-bred Wistar, HSD/Cpb:WU; Strain=Wistar; Sex=Female; Route=Subcutaneous; Maximum_Dose=1000; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol B; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Uterine weight increase vs control |
175 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 18; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=1008; Record_ID=endocrine_invivo_456; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=175; Response_Unit=%; Species=Rat; Reported_Strain=Hsd:SD; Strain=Sprague-Dawley; Sex=Female; Route=Subcutaneous; Maximum_Dose=1000; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol B; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Uterine weight increase vs control |
189 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 56 to 84; Age_Ovariectomized_or_Castrated=6 weeks; Time_Elapsed_Between_Surgery_and_Treatment=14 to 28 days; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=692; Record_ID=endocrine_invivo_366; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=189; Response_Unit=%; Species=Rat; Reported_Strain=SPF/VAF Crj:CD(SD)IGS; Strain=Sprague-Dawley; Sex=Female (ovariectomized); Route=Subcutaneous; Maximum_Dose=800; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol C; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Uterine weight increase vs control |
190 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 19 to 20; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=718; Record_ID=endocrine_invivo_379; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=190; Response_Unit=%; Species=Rat; Reported_Strain=Ap; Strain=Alderley Park; Sex=Female; Route=Subcutaneous; Maximum_Dose=600; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Experiment 1; Reference=Tinwell and Ashby 2004; 15064164; 10.1289/ehp.6831|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Uterine weight increase vs control |
203 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 56 to 84; Age_Ovariectomized_or_Castrated=6 weeks; Time_Elapsed_Between_Surgery_and_Treatment=14 to 28 days; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=724; Record_ID=endocrine_invivo_349; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=203; Response_Unit=%; Species=Rat; Reported_Strain=Crl:CD(SD)IGS BR; Strain=Sprague-Dawley; Sex=Female (ovariectomized); Route=Subcutaneous; Maximum_Dose=600.0; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol C; Reference=Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Uterine weight increase vs control |
205 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 56 to 84; Age_Ovariectomized_or_Castrated=6 weeks; Time_Elapsed_Between_Surgery_and_Treatment=14 to 28 days; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=699; Record_ID=endocrine_invivo_373; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=205; Response_Unit=%; Species=Rat; Reported_Strain=Crl:CD(SD)IGS BR; Strain=Sprague-Dawley; Sex=Female (ovariectomized); Route=Subcutaneous; Maximum_Dose=600.0; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol C; Reference=Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Uterine weight increase vs control |
216.7 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 21 to 22; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=7 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=737; Record_ID=endocrine_invivo_354; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=216.7; Response_Unit=%; Species=Rat; Reported_Strain=Alpk:APfSD; Strain=Alderley Park; Sex=Female; Route=Subcutaneous; Maximum_Dose=800.0; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Estradiol; Reference=Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Uterine weight increase vs control |
230 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 21; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=4 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=707; Record_ID=endocrine_invivo_360; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=230; Response_Unit=%; Species=Rat; Reported_Strain=SD; Strain=Sprague-Dawley; Sex=Female; Route=Subcutaneous; Maximum_Dose=200; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Estradiol; Reference=Ohno et al. 2003; 12453737; 10.1016/s0278-6915(02)00211-9|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Uterine weight increase vs control |
235 |
% |
Rat |
Subcutaneous |
Treatment_Duration=7 days; Age_at_First_Dose=PND 56 to 86; Age_Ovariectomized_or_Castrated=6 weeks; Time_Elapsed_Between_Surgery_and_Treatment=14 to 28 days; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=719; Record_ID=endocrine_invivo_380; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=235; Response_Unit=%; Species=Rat; Reported_Strain=Crj:CD(SD)IGS; Strain=Sprague-Dawley; Sex=Female (ovariectomized); Route=Subcutaneous; Maximum_Dose=800; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol D; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Uterine weight increase vs control |
251 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 18; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=700; Record_ID=endocrine_invivo_374; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=251; Response_Unit=%; Species=Rat; Reported_Strain=Crl:CD(SD)IGS BR; Strain=Sprague-Dawley; Sex=Female; Route=Subcutaneous; Maximum_Dose=600.0; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol B; Reference=Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |
| NTP_ICE_endocrine |
Uterine weight increase vs control |
253 |
% |
Rat |
Subcutaneous |
Treatment_Duration=7 days; Age_at_First_Dose=PND 56 to 85; Age_Ovariectomized_or_Castrated=6 weeks; Time_Elapsed_Between_Surgery_and_Treatment=14 to 28 days; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=697; Record_ID=endocrine_invivo_371; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID7020182; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=253; Response_Unit=%; Species=Rat; Reported_Strain=SPF/VAF Crj:CD(SD)IGS; Strain=Sprague-Dawley; Sex=Female (ovariectomized); Route=Subcutaneous; Maximum_Dose=800.0; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol D; Reference=Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID7020182; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID7020182 |